Straits Times Index
3,306.02 +6.02 (+0.18%) S&P 500
5,464.62 -8.55 (-0.16%) Dow
39,150.33 +15.53 (+0.04%) Nasdaq
17,689.36 -32.24 (-0.18%) Bitcoin USD
64,060.40 -221.15 (-0.34%) CMC Crypto 200
1,321.13 -39.20 (-2.88%)
Beijing Tiantan Biological Products Co., Ltd. (600161.SS)
Beijing Tiantan Biological Products Co., Ltd.
Courtyard No. 2
Shuangqiao Road Chaoyang District
Beijing 100024
China
86 10 6543 4018
https://www.tiantanbio.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4,858
Description
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include human albumin; intravenous human immunoglobulin; tetanus human immunoglobulin; rabies patient immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; and human prothrombin complex blood products. The company was founded in 1919 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. is a subsidiary of China National Biotec Group Company Limited.
Corporate governance
Beijing Tiantan Biological Products Co., Ltd.’s ISS governance QualityScore as of 1 June 2024 is 5. The pillar scores are Audit: 5; Board: 4; Shareholder rights: 5; Compensation: 7.
